inclusion criteria: 1. males or females 18 years of age or above and weighing 40kg or above at the time of providing informed consent. 2. a clinical diagnosis of thrombotic microangiopathy will then be applied to include the following criteria: i) d-dimer \> 100% the upper limit of the reference range and ii) serum creatinine \>25% of the normal range or iii) \>25% increase from patient's baseline serum creatinine. 3. diagnosis of sars-cov-2 infection within 90 days prior to enrollment

inclusion criteria: 1. males or females 18 years of age or above and weighing 40kg or above at the time of providing informed consent. 2. a clinical diagnosis of thrombotic microangiopathy will then be applied to include the following criteria: i) d-dimer \> 100% the upper limit of the reference range and ii) serum creatinine \>25% of the normal range or iii) \>25% increase from patient's baseline serum creatinine. 3. diagnosis of sars-cov-2 infection within 90 days prior to enrollment

inclusion criteria: males or females 18 years of age or above and weighing 40kg or above at the time of providing informed consent. a clinical diagnosis of thrombotic microangiopathy will then be applied to include the following criteria: i) d-dimer > 100% the upper limit of the reference range and ii) serum creatinine >25% of the normal range or iii) >25% increase from patient's baseline serum creatinine. diagnosis of sars-cov-2 infection within 90 days prior to enrollment

inclusion criteria: males or females 18 years of age or above and weighing 40kg or above at the time of providing informed consent. a clinical diagnosis of thrombotic microangiopathy will then be applied to include the following criteria: i) d-dimer > 100% the upper limit of the reference range and ii) serum creatinine >25% of the normal range or iii) >25% increase from patient's baseline serum creatinine. diagnosis of sars-cov-2 infection within 90 days prior to enrollment

inclusion criteria: 1. males or females 18 years of age or above and weighing 40kg or above at the time of providing informed consent. 2. a clinical diagnosis of thrombotic microangiopathy will then be applied to include the following criteria: i) d-dimer > 100% the upper limit of the reference range and ii) serum creatinine >25% of the normal range or iii) >25% increase from patient's baseline serum creatinine. 3. diagnosis of sars-cov-2 infection within 90 days prior to enrollment

inclusion criteria: 1. males or females 18 years of age or above and weighing 40kg or above at the time of providing informed consent. 2. a clinical diagnosis of thrombotic microangiopathy will then be applied to include the following criteria: i) d-dimer > 100% the upper limit of the reference range and ii) serum creatinine >25% of the normal range or iii) >25% increase from patient's baseline serum creatinine. 3. diagnosis of sars-cov-2 infection within 90 days prior to enrollment